IMMUNOSYN
Immunosyn Corporation owns the exclusive worldwide license to market a biopharmaceutical drug.
IMMUNOSYN
Industry:
Biopharma Health Care Pharmaceutical
Founded:
2006-01-01
Address:
San Diego, California, United States
Country:
United States
Status:
Active
Contact:
1-888-853-3663
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
More informations about "Immunosyn"
Immunosyn - Crunchbase Company Profile & Funding
Organization. Immunosyn . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Immunosyn Corporation owns the exclusive worldwide license to market a …See details»
Immunosyn Corp - Company Profile and News - Bloomberg Markets
Company profile page for Immunosyn Corp including stock price, company news, executives, board members, and contact informationSee details»
Company Immunosyn Corp - MarketScreener.com
Jul 8, 2011 Immunosyn Corp: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Other OTC: | Other OTCSee details»
SEC.gov | Stephen D. Ferrone, et al.
Aug 2, 2011 The Securities and Exchange Commission announced that on August 1, 2011, it charged Immunosyn Corporation ("Immunosyn") and Argyll Biotechnologies, LLC ("Argyll"), …See details»
SEC.gov | Stephen D. Ferrone, et al.
Jul 31, 2017 Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ... made materially …See details»
Immunosyn - Crunchbase
Immunosyn Corporation owns the exclusive worldwide license to market a biopharmaceutical drug.See details»
Immunosyn Corp. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Immunosyn Corp. with its drug pipeline, therapeutic area, technology platform, , Drug:SF-1019.See details»
PRESS RELEASE: Immunosyn Corporation Names Stephen Ferrone …
Oct 23, 2007 Immunosyn Corporation Names Stephen Ferrone as CEO LA JOLLA, Calif., Oct. 23 -- Immunosyn Corporation has announced the appointment of Stephen D. Ferrone as the …See details»
Immunosyn Corp. - BioCentury Company Profiles - BCIQ
Immunosyn Corp. - BioCentury Company Profiles for the biopharma industrySee details»
Immunosyn Corporation Announces the Successful Completion of …
Jan 18, 2008 The Board of Immunosyn was advised as to the success of this important phase of the "Proof of Concept Trial" by Argyll Biotechnologies, LLC its strategic partner and largest …See details»
U.S. SEC charges Immunosyn with securities fraud | Reuters
Aug 2, 2011 U.S. securities regulators charged Immunosyn Corp <IMYN.PK>, a California-based biopharmaceutical company, with misleading investors about the regulatory status of …See details»
Immunosyn Corporation Names New CEO - BioSpace
Oct 24, 2007 About Immunosyn Corporation La Jolla, CA-headquartered Immunosyn Corporation plans to market and distribute life enhancing therapeutics. Currently, the company …See details»
Immunosyn Corporation Releases SF-1019 Study Results
Nov 8, 2007 About Immunosyn Corporation La Jolla, CA-headquartered Immunosyn Corporation (IMYN.OTC.BB) plans to market and distribute life enhancing therapeutics. Currently, the …See details»
SEC.gov | Stephen D. Ferrone, et al.
May 3, 2016 The SEC charged Ferrone and other defendants in August 2011, alleging, among other things, that Ferrone made materially false and misleading statements during 2007-2010 …See details»
Immunosyn Gets the Go-Ahead to Manufacture Its First …
Nov 28, 2007 Biozyme Laboratories received approval to import base material and manufacture Immunosyn’s preclinical compound for use in clinical trials in the U.K. SF-1019 has been …See details»
SEC Enforcement Director Statement on Jury Finding That CEO …
Apr 29, 2016 Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock (A locked ... “We …See details»
Latest news about Immunosyn Corp - MarketScreener
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With …See details»
SEC lays out "tall tales" in $20M biotech securities scam
Aug 3, 2011 According to executives at Immunosyn and its controlling shareholder Argyll Biotechnologies, the biotech was onto something truly special. Its lead drug, SF-1019, which …See details»
Analysis Immunosyn Corp MarketScreener
Immunosyn Corp: Trading strategies, financial analysis, commentaries and investment guidance for Immunosyn Corp Stock | Other OTC: | Other OTCSee details»
Immunosin: Uses, Dosage, Side Effects, FAQ - MedicinesFAQ
Sep 19, 2023 Immunosin is a medication used to treat subacute sclerosing panencephalitis.Immunosin is also indicated for mucocutaneous infections due to herpes …See details»